Bioceltix S.A. (WSE:BCX)
Poland flag Poland · Delayed Price · Currency is PLN
99.60
-1.20 (-1.19%)
Oct 6, 2025, 10:42 AM CET

Bioceltix Income Statement

Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21
Cost of Revenue
1.681.431.040.70.85
Gross Profit
-1.68-1.43-1.04-0.7-0.85
Selling, General & Admin
14.1216.3614.028.094.81
Other Operating Expenses
-2.29-3.27-1.48-0.29-1.64
Operating Expenses
12.5413.6612.988.253.55
Operating Income
-14.22-15.09-14.02-8.95-4.4
Interest Expense
-0.22-0.17-0.03-0.03-0.02
Interest & Investment Income
0.530.420.28-0.01
Currency Exchange Gain (Loss)
-0.08-0.090.08-0.04-0
EBT Excluding Unusual Items
-13.99-14.92-13.69-9.02-4.42
Gain (Loss) on Sale of Assets
0.020.05-0.050.07
Pretax Income
-13.96-14.87-13.69-8.97-4.36
Income Tax Expense
0.030.03-0.01-0.050.04
Net Income
-14-14.9-13.69-8.92-4.4
Net Income to Common
-14-14.9-13.69-8.92-4.4
Shares Outstanding (Basic)
55433
Shares Outstanding (Diluted)
55433
Shares Change (YoY)
19.13%15.76%17.48%5.54%-
EPS (Basic)
-2.84-3.28-3.49-2.67-1.39
EPS (Diluted)
-2.84-3.28-3.49-2.67-1.39
Free Cash Flow
-14.14-17.81-15.21-8.23-4.02
Free Cash Flow Per Share
-2.87-3.93-3.88-2.47-1.27
EBITDA
-13.5-14.51-13.58-8.51-4.03
D&A For EBITDA
0.720.570.430.450.38
EBIT
-14.22-15.09-14.02-8.95-4.4
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.